FIELD: organic chemistry, pharmacy. SUBSTANCE: invention relates to new triazolyl-substituted compounds of tertiary amine of the formula (I) where A - a simple bond; B - lower alkyl, group (a) , naphthyl, pyridyl, thienyl, thiazolyl, benzotriazolyl, quinolyl, benzofurazanyl or benzothiazolyl that can be substituted with halogen or alkyl; D - a ring group (b) or benzofurazanyl; E - a ring 4H-1,2,4-triazolyl or 1H-1,2,4-triazolyl; R1 - - H, halogen, cyano-, nitro-group, CF3, lower alkyl or alkoxy; R2 - is hydrogen or halogen; R3 - - halogen, cyano-, nitro-group, CF3 or amino-group at condition that if both R1 and R2 are chlorine atom then A - methylene group. Compound (I) or its salt exhibits activity inhibiting aromatase. EFFECT: new compounds indicated above, improved method of synthesis. 8 cl, 19 ex
Title | Year | Author | Number |
---|---|---|---|
BIS-OXADIAZOLIDINEDIONE DERIVATIVES, PHARMACEUTICAL COMPOSITION | 1994 |
|
RU2135487C1 |
HETEROBICYCLIC DERIVATIVES, METHODS OF THEIR SYNTHESIS AND PHARMACEUTICAL COMPOSITION | 1995 |
|
RU2170737C2 |
THIOPHENE DERIVATIVE AND PHARMACEUTICAL COMPOSITION BASED ON THEREOF | 1997 |
|
RU2172737C2 |
FGFR INHIBITOR AND ITS APPLICATION | 2018 |
|
RU2745035C1 |
METHODS AND COMPOSITIONS FOR TARGETED PROTEIN DEGRADATION | 2020 |
|
RU2820673C2 |
PYRROLO[2,1-f][1,2,4]TRIAZINE COMPOUND, METHOD FOR PRODUCTION AND USE THEREOF | 2013 |
|
RU2589053C1 |
COMPOUND WITH ANTI-CANCER ACTIVITY | 2019 |
|
RU2809763C2 |
POLYPEPTIDE COMPOUND, METHOD OF ITS SYNTHESIS AND PHARMACEUTICAL COMPOSITION | 1995 |
|
RU2165423C2 |
1,2,4-TRIAZOLONE DERIVATIVE | 2011 |
|
RU2566754C2 |
DERIVATIVES OF AZOLE, PHARMACEUTICAL COMPOSITION BASED ON THEREOF, INTERMEDIATE COMPOUNDS | 1995 |
|
RU2161612C2 |
Authors
Dates
1998-12-27—Published
1992-08-27—Filed